{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T15:49:19Z","timestamp":1782920959090,"version":"3.54.5"},"reference-count":9,"publisher":"The Endocrine Society","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Hypertension in infancy is rare and usually secondary to renal, cardiovascular, or endocrine disorders. PASNA syndrome (primary aldosteronism, seizures, and neurological abnormalities) (OMIM #615474) caused by activating CACNA1D mutations, has been increasingly recognized with wider availability of genetic testing. We report a 5-month-old male infant with incidentally detected severe hypertension (&amp;gt;99th percentile), neonatal jitteriness, and global developmental delay. Laboratory evaluation showed markedly elevated aldosterone (824\u2005ng\/dL) (SI: 22.9\u2005nmol\/L) (reference range, 5-150\u2005ng\/dL [SI: 0.14-4.2\u2005nmol\/L]) with low-normal renin and normal renal and cardiac imaging. Genetic analysis revealed a heterozygous CACNA1D missense variant (c.2241C &amp;gt; G; p.Phe747Leu) likely pathogenic and a heterozygous MED12L variant, classified as variants of unknown significance. The mother was an asymptomatic carrier of the CACNA1D variant. Blood pressure improved with nifedipine followed by spironolactone (2.5\u2005mg\/kg\/day). Neurological symptoms partially improved, though motor delay persisted. This case expands the phenotypic spectrum of PASNA syndrome and highlights the need for early genetic evaluation in infants with unexplained hypertension and neurological abnormalities. The concurrent MED12L variant may contribute to the neurodevelopmental phenotype, underscoring the complexity of dual-gene involvement.<\/jats:p>","DOI":"10.1210\/jcemcr\/luag131","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T11:30:20Z","timestamp":1776771020000},"source":"Crossref","is-referenced-by-count":0,"title":["PASNA syndrome with overlapping\n                    <i>CACNA1D<\/i>\n                    and\n                    <i>MED12L<\/i>\n                    variants: expanding the spectrum"],"prefix":"10.1210","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-9993-7191","authenticated-orcid":false,"given":"Bhanu Teja","family":"Nalluri","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Osmania Medical College , Hyderabad 500001 ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9253-387X","authenticated-orcid":false,"given":"Neelaveni","family":"Kudugunti","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Osmania Medical College , Hyderabad 500001 ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5471-0695","authenticated-orcid":false,"given":"Rakesh Kumar","family":"Sahay","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Osmania Medical College , Hyderabad 500001 ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkatesh","family":"Santhoju","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Osmania Medical College , Hyderabad 500001 ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"issue":"9","key":"2026070107294458400_luag131-B1","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/ng.2695","article-title":"Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism","volume":"45","author":"Scholl","year":"2013","journal-title":"Nat Genet"},{"issue":"4","key":"2026070107294458400_luag131-B2","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1093\/ejendo\/lvae041","article-title":"Familial hyperaldosteronism: an European reference network on rare endocrine conditions clinical practice guideline","volume":"190","author":"Mulatero","year":"2024","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"2026070107294458400_luag131-B3","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.biopsych.2014.11.020","article-title":"CACNA1D de novo mutations in autism spectrum disorders activate Cav1.3 L-type calcium channels","volume":"77","author":"Pinggera","year":"2015","journal-title":"Biol Psychiatry"},{"issue":"5","key":"2026070107294458400_luag131-B4","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/hmg\/ddac248","article-title":"Germline de novo variant F747S extends the phenotypic spectrum of CACNA1D Ca2+ channelopathies","volume":"32","author":"T\u00f6r\u00f6k","year":"2023","journal-title":"Hum Mol Genet"},{"issue":"1","key":"2026070107294458400_luag131-B5","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/19336950.2020.1761171","article-title":"A de novo CACNA1D missense mutation in a patient with congenital hyperinsulinism, primary hyperaldosteronism and hypotonia","volume":"14","author":"De Mingo Alemany","year":"2020","journal-title":"Channels (Austin)"},{"issue":"12","key":"2026070107294458400_luag131-B6","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1038\/s41436-019-0557-3","article-title":"Variants in MED12L, encoding a subunit of the mediator kinase module, are responsible for intellectual disability associated with transcriptional defect","volume":"21","author":"Nizon","year":"2019","journal-title":"Genet Med"},{"issue":"9","key":"2026070107294458400_luag131-B7","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/ng.2716","article-title":"Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension","volume":"45","author":"Azizan","year":"2013","journal-title":"Nat Genet"},{"issue":"1","key":"2026070107294458400_luag131-B8","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1080\/19336950.2018.1546518","article-title":"Gating defects of disease-causing de novo mutations in Cav1.3 Ca2+ channels","volume":"12","author":"Pinggera","year":"2018","journal-title":"Channels (Austin)"},{"issue":"20","key":"2026070107294458400_luag131-B9","doi-asserted-by":"crossref","first-page":"5839","DOI":"10.1113\/JP270672","article-title":"Cav1. 3 (CACNA1D) L-type Ca2+ channel dysfunction in CNS disorders","volume":"594","author":"Pinggera","year":"2016","journal-title":"J Physiol"}],"container-title":["JCEM Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/4\/7\/luag131\/68664485\/luag131.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/4\/7\/luag131\/68664485\/luag131.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T15:20:15Z","timestamp":1782919215000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcemcr\/article\/doi\/10.1210\/jcemcr\/luag131\/8722854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":9,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,5,20]]}},"URL":"https:\/\/doi.org\/10.1210\/jcemcr\/luag131","relation":{},"ISSN":["2755-1520"],"issn-type":[{"value":"2755-1520","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7]]},"published":{"date-parts":[[2026,5,20]]},"article-number":"luag131"}}